The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Myelodysplastic Syndromes
Open accessAbstract
These suggested practice guidelines are based on extensive evaluation of the reviewed risk-based data and indicate useful current approaches for managing patients with MDS. Four drugs have recently been approved by the FDA for treating specific subtypes of MDS: lenalidomide for MDS patients with del(5q) cytogenetic abnormalities; azacytidine and decitabine for treating patients with higher-risk or nonresponsive MDS; and deferasirox for iron chelation of iron overloaded patients with MDS. However, because a substantial proportion of patient subsets with MDS lack effective treatment for their cytopenias or for altering disease natural history, clinical trials with these and other novel therapeutic agents along with supportive care remain the hallmark of management for this disease. The role of thrombopoietic cytokines for management of thrombocytopenia in MDS needs further evaluation. In addition, further determination of the effects of these therapeutic interventions on the patient's quality of life is important.(116,119,120,128,129) Progress toward improving management of MDS has occurred over the past few years, and more advances are anticipated using these guidelines as a framework for coordination of comparative clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
World Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Self-citationVardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Self-citationProposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
Self-citationWHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008)
(2015) · Postgraduate Haematology · doi:10.1002/9781118853771.ch51 · Cited by 3,290
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Self-citationFenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Self-citationThe World Health Organization (WHO) classification of the myeloid neoplasms
Vardiman, J. W., Harris, N. L., & Brunning, R. D. (2002) · Blood · doi:10.1182/blood-2002-04-1199 · Cited by 2,197
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,857
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Self-citationKantarjian, H., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,530
Self-citationLenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Self-citationProposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb02771.x · Cited by 1,275
Self-citationGiralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Iron-Chelating Therapy and the Treatment of Thalassemia
Olivieri, N. F., & Brittenham, G. M. (1997) · Blood · doi:10.1182/blood.v89.3.739 · Cited by 1,089
Malcovati, L., Germing, U., Kuendgen, A., Della Porta, M. G., Pascutto, C., Invernizzi, R., Giagounidis, A., Hildebrandt, B., Bernasconi, P., Knipp, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5696 · Cited by 1,032
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
St. Pierre, T. G., Clark, P. R., Chua-anusorn, W., Fleming, A. J., Jeffrey, G. P., Olynyk, J. K., Pootrakul, P., Robins, E., & Lindeman, R. (2005) · Blood · doi:10.1182/blood-2004-01-0177 · Cited by 909
Efficacy of Lenalidomide in Myelodysplastic Syndromes
List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D., Fuchs, D., Rimsza, L., Heaton, R., Knight, R., & Zeldis, J. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041668 · Cited by 880
Malcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
Kantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Self-citationCheson, B. D., Bennett, J. M., Kantarjian, H. M., Pinto, A., Schiffer, C. A., Nimer, S. D., Löwenberg, B., Beran, M., de Witte, T. M., Stone, R. M., et al. (2000) · PubMed · Cited by 666
Self-citationApperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020150 · Cited by 630
Wijermans, P., Lübbert, M., Verhoef, G., Bosly, A., Ravoet, C., Andre, M., & Ferrant, A. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.956 · Cited by 567
Silverman, L. R., McKenzie, D. R., Peterson, B. L., Holland, J. F., Backstrom, J. T., Beach, C. L., & Larson, R. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4346 · Cited by 552
Lübbert, M., Suciu, S., Baila, L., Rüter, B. H., Platzbecker, U., Giagounidis, A., Selleslag, D., Labar, B., Germing, U., Salih, H. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.9245 · Cited by 552
Valent, P., Horny, H.-P., Bennett, J. M., Fonatsch, C., Germing, U., Greenberg, P., Haferlach, T., Haase, D., Kolb, H.-J., Krieger, O., et al. (2007) · Leukemia Research · doi:10.1016/j.leukres.2006.11.009 · Cited by 513
Self-citationSteensma, D. P., Dewald, G. W., Lasho, T. L., Powell, H. L., McClure, R. F., Levine, R. L., Gilliland, D. G., & Tefferi, A. (2005) · Blood · doi:10.1182/blood-2005-03-1183 · Cited by 466
Hellström‐Lindberg, E., Gulbrandsen, N., Lindberg, G., Ahlgren, T., Dahl, I. M. S., Dybedal, I., Grimfors, G., Hesse‐Sundin, E., Hjorth, M., Kanter‐Lewensohn, L., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04153.x · Cited by 458
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H., Sultan, C., & Cox, C. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb06734.x · Cited by 432
Self-citationRaza, A., Reeves, J. A., Feldman, E. J., Dewald, G. W., Bennett, J. M., Deeg, H. J., Dreisbach, L., Schiffer, C. A., Stone, R. M., Greenberg, P. L., et al. (2008) · Blood · doi:10.1182/blood-2007-01-068833 · Cited by 425
Self-citationKornblith, A. B., Herndon, J. E., Silverman, L. R., Demakos, E. P., Odchimar-Reissig, R., Holland, J. F., Powell, B. L., DeCastro, C., Ellerton, J., Larson, R. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.044 · Cited by 419
Self-citationWells, D. A., Benesch, M., Loken, M. R., Vallejo, C., Myerson, D., Leisenring, W. M., & Deeg, H. J. (2003) · Blood · doi:10.1182/blood-2002-09-2768 · Cited by 358
Self-citationPark, S., Grabar, S., Kelaidi, C., Beyne-Rauzy, O., Picard, F., Bardet, V., Coiteux, V., Leroux, G., Lepelley, P., Daniel, M.-T., et al. (2008) · Blood · doi:10.1182/blood-2007-06-096370 · Cited by 334
Self-citationNisbet-Brown, E., Olivieri, N. F., Giardina, P. J., Grady, R. W., Neufeld, E. J., Séchaud, R., Krebs-Brown, A. J., Anderson, J. R., Alberti, D., Sizer, K. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13309-0 · Cited by 328
Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone
Cohen, A. R., Galanello, R., Piga, A., De Sanctis, V., & Tricta, F. (2003) · Blood · doi:10.1182/blood-2002-10-3280 · Cited by 323
Hellström‐Lindberg, E., Negrin, R., Stein, R., Krantz, S., Lindberg, G., Vardiman, J., ÖSt, Å., & Greenberg, P. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4013211.x · Cited by 312
Self-citationRaza, A., Meyer, P., Dutt, D., Zorat, F., Lisak, L., Nascimben, F., du Randt, M., Kaspar, C., Goldberg, C., Loew, J., et al. (2001) · Blood · doi:10.1182/blood.v98.4.958 · Cited by 305
Hellström-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., et al. (1998) · Blood · doi:10.1182/blood.v92.1.68.413k23_68_75 · Cited by 304
Alyea, E. P., Kim, H. T., Ho, V., Cutler, C., Gribben, J., DeAngelo, D. J., Lee, S. J., Windawi, S., Ritz, J., Stone, R. M., et al. (2005) · Blood · doi:10.1182/blood-2004-05-1947 · Cited by 300
Self-citationJädersten, M., Malcovati, L., Dybedal, I., Giovanni Della Porta, M., Invernizzi, R., Montgomery, S. M., Pascutto, C., Porwit, A., Cazzola, M., & Hellström-Lindberg, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4906 · Cited by 300
Germing, U., Gattermann, N., Strupp, C., Aivado, M., & Aul, C. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00088-6 · Cited by 296
Clinical Consequences of Acquired Transfusional Iron Overload in Adults
Schafer, A. I., Cheron, R. G., Dluhy, R., Cooper, B., Gleason, R. E., Soeldner, J. S., & Bunn, H. F. (1981) · New England Journal of Medicine · doi:10.1056/nejm198102053040603 · Cited by 295
Paroxysmal Nocturnal Hemoglobinuria Cells in Patients with Bone Marrow Failure Syndromes
Dunn, D. E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S. W., Kirby, M. R., Kumar, M. S. A., Rosenfeld, S., & Young, N. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-6-199909210-00002 · Cited by 279
Sloand, E. M., Wu, C. O., Greenberg, P., Young, N., & Barrett, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9214 · Cited by 277
Self-citationAntithymocyte globulin for patients with myelodysplastic syndrome
Molldrem, J. J., Caples, M., Mavroudis, D., Plante, M., Young, N. S., & Barrett, A. J. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.4423249.x · Cited by 275
Noninvasive measurement of iron: report of an NIDDK workshop
Brittenham, G. M., & Badman, D. G. (2003) · Blood · doi:10.1182/blood-2002-06-1723 · Cited by 274
Saunthararajah, Y., Nakamura, R., Nam, J.-M., Robyn, J., Loberiza, F., Maciejewski, J. P., Simonis, T., Molldrem, J., Young, N. S., & Barrett, A. J. (2002) · Blood · doi:10.1182/blood.v100.5.1570.h81702001570_1570_1574 · Cited by 273
Pathophysiology of Iron Overloada
HERSHKO, C., LINK, G., & CABANTCHIK, I. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10475.x · Cited by 248
Scott, B. L., Sandmaier, B. M., Storer, B., Maris, M. B., Sorror, M. L., Maloney, D. G., Chauncey, T. R., Storb, R., & Deeg, H. J. (2006) · Leukemia · doi:10.1038/sj.leu.2404010 · Cited by 235
Self-citationGreenberg, P. L., Lee, S. J., Advani, R., Tallman, M. S., Sikic, B. I., Letendre, L., Dugan, K., Lum, B., Chin, D. L., Dewald, G., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.048 · Cited by 235
Self-citationCopper deficiency masquerading as myelodysplastic syndrome
Gregg, X. T., Reddy, V., & Prchal, J. T. (2002) · Blood · doi:10.1182/blood-2002-01-0256 · Cited by 230
Castro-Malaspina, H., Harris, R. E., Gajewski, J., Ramsay, N., Collins, R., Dharan, B., King, R., & Deeg, H. J. (2002) · Blood · doi:10.1182/blood.v99.6.1943 · Cited by 227
Self-citationLubbert, M., Wijermans, P., Kunzmann, R., Verhoef, G., Bosly, A., Ravoet, C., Andre, M., & Ferrant, A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02933.x · Cited by 224
Szpurka, H., Tiu, R., Murugesan, G., Aboudola, S., Hsi, E. D., Theil, K. S., Sekeres, M. A., & Maciejewski, J. P. (2006) · Blood · doi:10.1182/blood-2006-02-005751 · Cited by 209
Greenberg, P. L., Sun, Z., Miller, K. B., Bennett, J. M., Tallman, M. S., Dewald, G., Paietta, E., van der Jagt, R., Houston, J., Thomas, M. L., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211797 · Cited by 208
Self-citationGalton, D. A. (1989) · BMJ · doi:10.1136/bmj.299.6699.582 · Cited by 206
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload
Jensen, P. D., Heickendorff, L., Pedersen, B., Bendix‐Hansen, K., Jensen, F. T., Christensen, T., Boesen, A. M., & Ellegaard, J. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1795.x · Cited by 202
Alessandrino, E. P., Della Porta, M. G., Bacigalupo, A., Van Lint, M. T., Falda, M., Onida, F., Bernardi, M., Iori, A. P., Rambaldi, A., Cerretti, R., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143735 · Cited by 195
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome
Ogata, K. (2002) · Blood · doi:10.1182/blood-2002-01-0222 · Cited by 186
Jensen, P. D., Jensen, F. T., Christensen, T., Eiskjær, H., Baandrup, U., & Nielsen, J. L. (2003) · Blood · doi:10.1182/blood-2002-09-2754 · Cited by 174
Estey, E. H., Thall, P. F., Cortes, J. E., Giles, F. J., O'Brien, S., Pierce, S. A., Wang, X., Kantarjian, H. M., & Beran, M. (2001) · Blood · doi:10.1182/blood.v98.13.3575 · Cited by 165
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients
Olivieri, N. F., Freedman, M. H., Koren, G., Hermann, C., Bentur, Y., Chung, D., Klein, J., Olivieri, N. F., Koren, G., Freedman, M. H., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)92962-h · Cited by 162
Nevill, T. J., Fung, H. C., Shepherd, J. D., Horsman, D. E., Nantel, S. H., Klingemann, H.-G., Forrest, D. L., Toze, C. L., Sutherland, H. J., Hogge, D. E., et al. (1998) · Blood · doi:10.1182/blood.v92.6.1910 · Cited by 161
Advani, R., Saba, H. I., Tallman, M. S., Rowe, J. M., Wiernik, P. H., Ramek, J., Dugan, K., Lum, B., Villena, J., Davis, E., et al. (1999) · Blood · doi:10.1182/blood.v93.3.787 · Cited by 158
Self-citationThalidomide for the treatment of patients with myelodysplastic syndromes
Strupp, C., Germing, U., Aivado, M. A., Misgeld, E., Haas, R. R., & Gattermann, N. (2002) · Leukemia · doi:10.1038/sj.leu.2402330 · Cited by 150
Malcovati, L. (2007) · Leukemia Research · doi:10.1016/s0145-2126(07)70459-9 · Cited by 132
Myelodysplastic syndrome is not merely “preleukemia”
Albitar, M. X., Manshouri, T., Shen, Y., Liu, D., Beran, M., Kantarjian, H. M., Rogers, A. M., Jilani, I. B., Lin, C., Pierce, S. A., et al. (2002) · Blood · doi:10.1182/blood.v100.3.791 · Cited by 129
Ablative Allogeneic Hematopoietic Cell Transplantation in Adults 60 Years of Age and Older
Wallen, H. D., Gooley, T. A., Deeg, H. J., Pagel, J. M., Press, O. W., Appelbaum, F. R., Storb, R. F., & Gopal, A. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.694 · Cited by 127
Self-citationNösslinger, T., Reisner, R., Koller, E., Grüner, H., Tüchler, H., Nowotny, H., Pittermann, E., & Pfeilstöcker, M. (2001) · Blood · doi:10.1182/blood.v98.10.2935 · Cited by 119
Kantarjian, H. M., O'Brien, S. M., Shan, J., Aribi, A. M., Garcia‐Manero, G., Jabbour, E. J., Ravandi, F., Cortes, J. E., Davisson, J., & Issa, J. J. (2006) · Cancer · doi:10.1002/cncr.22376 · Cited by 115
Self-citationWho is fit for allogeneic transplantation?
Deeg, H. J., & Sandmaier, B. M. (2010) · Blood · doi:10.1182/blood-2010-07-259358 · Cited by 113
Self-citationMorphology and classification of the myelodysplastic syndromes and their pathologic variants.
Kouides, P. A., & Bennett, J. M. (1996) · PubMed · Cited by 113
Self-citationSpiriti, M. A. A., Latagliata, R., Niscola, P., Cortelezzi, A., Francesconi, M., Ferrari, D., Volpe, E., Clavio, M., Grossi, A., Reyes, M. T., et al. (2004) · Annals of Hematology · doi:10.1007/s00277-004-0961-9 · Cited by 107
Deeg, H. J., Gotlib, J. R., Beckham, C., Dugan, K., Holmberg, L., Schubert, M., Appelbaum, F. R., & Greenberg, P. L. (2002) · Leukemia · doi:10.1038/sj.leu.2402356 · Cited by 104
Self-citationKao, J. M., McMillan, A., & Greenberg, P. L. (2008) · American Journal of Hematology · doi:10.1002/ajh.21249 · Cited by 103
Self-citationPrognostic factors and scoring systems in myelodysplastic syndromes.
Sanz, G. F., Sanz, M. Á., & Greenberg, P. L. (1998) · PubMed · Cited by 102
Self-citationMannone, L., Gardin, C., Quarré, M. C., Bernard, J. F., Vassilieff, D., Adès, L., Park, S., Vaultier, S., Hamza, F., Beyne‐rauzy, M. O., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06070.x · Cited by 100
Oxidative Stress and the Myelodysplastic Syndromes
Farquhar, M. J., & Bowen, D. (2003) · International Journal of Hematology · doi:10.1007/bf02982641 · Cited by 96
Stasi, R., Abruzzese, E., Lanzetta, G., Terzoli, E., & Amadori, S. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi400 · Cited by 96
Darbepoetin alpha for the treatment of anaemia in low‐intermediate risk myelodysplastic syndromes
Musto, P., Lanza, F., Balleari, E., Grossi, A., Falcone, A. P., Sanpaolo, G., Bodenizza, C., Scalzulli, P. R., Sala, A. L., Campioni, D., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05288.x · Cited by 95
Circulating erythropoietin in patients with myelodysplastic syndromes
Jacobs, A., Janowska‐Wieczorek, A., Caro, J., Bowen, D., & Lewis, T. (1989) · British Journal of Haematology · doi:10.1111/j.1365-2141.1989.tb00215.x · Cited by 89
van den Bosch, J., Lübbert, M., Verhoef, G. E. G., & Wijermans, P. (2004) · Leukemia Research · doi:10.1016/j.leukres.2003.11.016 · Cited by 88
Oliansky, D. M., Antin, J. H., Bennett, J. M., Deeg, H. J., Engelhardt, C., Heptinstall, K. V., Lima, M. J. G. D., Gore, S. D., Potts, R. G., Silverman, L. R., et al. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.12.003 · Cited by 84
Self-citationMyelodysplastic Syndromes: Iron Overload Consequences and Current Chelating Therapies
Greenberg, P. L. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0010 · Cited by 83
Self-citationAllogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
Kerbauy, D. M. B., Chyou, F., Gooley, T. A., Sorror, M. L., Scott, B. L., Pagel, J. M., Myerson, D., Appelbaum, F. R., Storb, R. F., & Deeg, H. J. (2005) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.05.008 · Cited by 76
Self-citationProblematic WHO Reclassification of Myelodysplastic Syndromes
Members of the International MDS Study Group, & Head, D. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3447 · Cited by 75
Self-citationJurado, M., Deeg, H. J., Storer, B. E., Anasetti, C., Anderson, J. E., Bryant, E. M., Chauncey, T. R., Doney, K., Flowers, M. E. D., Hansen, J. A., et al. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm11939606 · Cited by 68
Self-citationMalcovati, L., Porta, M. G. D., Pascutto, C., Malabarba, L., Travaglino, E., Passamonti, F., Invernizzi, R., Lazzarino, M., & Cazzola, M. (2004) · Blood · doi:10.1182/blood.v104.11.1430.1430 · Cited by 61
Clinical Management of Myelodysplastic Syndromes With Interstitial Deletion of Chromosome 5q
Nimer, S. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6715 · Cited by 56
Self-citationPark, M. J., Kim, H., Kim, S., Kim, D. H., Kim, S. J., Jang, J. H., Kım, K., Kim, W. S., & Jung, C. W. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01124.x · Cited by 51
The evolution of hematopoietic SCT in myelodysplastic syndrome
Kindwall‐Keller, T. L., & Isola, L. M. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.28 · Cited by 49
Myelodysplastic/Myeloproliferative Neoplasms
Foucar, K. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpj71ptvikgevt · Cited by 49
Saba, H. I., Rosenfeld, C. S., Issa, J. J., DiPersio, J. F., Raza, A., Klimek, V. M., Slack, J. L., de Castro, C., Mettinger, K. L., & Kantarjian, H. M. (2004) · Blood · doi:10.1182/blood.v104.11.67.67 · Cited by 41
[Secondary hemochromatosis in polytransfused patients with myelodysplastic syndromes].
Jaeger, M., Aul, C., Söhngen, D., Germing, U., & Schneider, W. (1992) · PubMed · Cited by 39
Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts
Koca, E., Büyükaşık, Y., Çetiner, D., Yılmaz, R., Sayınalp, N., Yasavul, Ü., & Üner, A. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.06.023 · Cited by 37
Acute myeloid leukaemia with myelodysplasia‐related changes
ChB, F. M. L. M., & BS, F. B. J. B. M. (2021) · doi:10.1002/9781119777663.ch93 · Cited by 36
Wattel, E., Solary, É., Hecquet, B., Caillot, D., Ifrah, N., Brion, A., Milpied, N. J., Janvier, M., Guerci‐Bresler, A., Rochant, H., et al. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_5 · Cited by 33
Optimization of Transplant Regimens for Patients with Myelodysplastic Syndrome (MDS)
Deeg, H. J. (2005) · Hematology · doi:10.1182/asheducation-2005.1.167 · Cited by 31
Self-citationNCCN Task Force: Transfusion and Iron Overload in Patients With Myelodysplastic Syndromes
Greenberg, P. L., Rigsby, C. K., Stone, R. M., Deeg, H. J., Gore, S. D., Millenson, M. M., Nimer, S. D., O'Donnell, M. R., Shami, P. J., & Kumar, R. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0082 · Cited by 29
Self-citationManagement of patients with higher risk myelodysplastic syndromes
Fukumoto, J. S., & Greenberg, P. L. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.04.006 · Cited by 24
Self-citationEfficacy of Lenalidomide in Myelodysplastic Syndromes
Gordon, M. S. (2006) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70122-2 · Cited by 21
Cited by
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Greenberg, P. L., Tuechler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Solé, F., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., et al. (2012) · Blood · doi:10.1182/blood-2012-03-420489 · Cited by 2,844
Self-citationBejar, R., Stevenson, K. E., Caughey, B. A., Abdel-Wahab, O., Steensma, D. P., Galili, N., Raza, A., Kantarjian, H., Levine, R. L., Neuberg, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7379 · Cited by 441
Self-citationSteensma, D. P., Baer, M. R., Slack, J. L., Buckstein, R., Godley, L. A., Garcia-Manero, G., Albitar, M., Larsen, J. S., Arora, S., Cullen, M. T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6550 · Cited by 319
Self-citationKoreth, J., Pidala, J., Perez, W. S., Deeg, H. J., Garcia-Manero, G., Malcovati, L., Cazzola, M., Park, S., Itzykson, R., Ades, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8652 · Cited by 284
Self-citation
Metadata
- Authors
- Greenberg, P. L., Attar, E., Bennett, J. M., Bloomfield, C. D., De Castro, C. M., Deeg, H. J., Foran, J. M., Gaensler, K., Garcia-Manero, G., Gore, S. D., Head, D., Komrokji, R., Maness, L. J., Millenson, M., Nimer, S. D., O'Donnell, M. R., Schroeder, M. A., Shami, P. J., Stone, R. M., Thompson, J. E., & Westervelt, P.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2011-01
- Volume
- 9
- Issue
- 1
- Pages
- 30-56
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W1581590112
- Cited by
- 290
- References
- 106
- FWCI
- 26.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.